Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Kaplan Fox Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Seek Leadership in a Securities Fraud Lawsuit by September 28, 2026
Via NewMediaWire
Topics Fraud Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Notifies Investors of Medline Inc. (NASDAQ: MDLN) of an Investigation Into Potential Securities Law Violations
Via NewMediaWire
Tickers BAC MDLN
Exposures Product Safety
News headline image
Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
Via Newsfile
Tickers PHIO
Exposures Product Safety
News headline image
Iovance Biotherapeutics Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers IOVA
Exposures Financial Product Safety
Revolution Medicines (NASDAQ:RVMD) Misses Q2 Estimates, Yet FDA Accepts Daraxonrasib Application ↗
Via Chartmill
Tickers RVMD
Exposures Product Safety
News headline image
Kaplan Fox Notifies Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) of an Investigation Into Potential Securities Law Violations
Via NewMediaWire
Tickers FULC
Exposures Product Safety
News headline image
Takeda Achieves Major Milestone With Holistic Narcolepsy Drug Approval ↗
Via Benzinga
Exposures Product Safety
News headline image
Beyond COVID: Moderna Wins FDA Approval for Its Seasonal Flu Vaccine ↗
Via Benzinga
Exposures Product Safety
News headline image
Amylyx Pharmaceuticals Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers AMLX
Exposures Financial Product Safety
News headline image
Crrow777 Radio 691: Addiction Recovery and Sleep, With Jeff Nunn of Project Biohacking
Via PRUnderground
Exposures Product Safety
News headline image
Moderna Wavers Despite Hard-Fought FDA Win; Will Its Sprint Restart? ↗
Via Investor's Business Daily
Exposures Product Safety
News headline image
StreetWatch: A $2.9 Billion Takeover Put a Spotlight on Relentless Hunger. Palatin Technologies Is Developing the Next Generation of the Drug That Seeks to Treat It
Via Newsfile
Tickers PTN
Exposures Product Safety
News headline image
What Is a Regulatory Writing Course? A Complete Beginner's Guide ↗
Via Talk Markets
Exposures Product Safety
News headline image
Vanda Pharmaceuticals Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers VNDA
Exposures Financial Product Safety
News headline image
Revolution Medicines Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers RVMD
Exposures Financial Product Safety
News headline image
OraSure Technologies Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers OSUR
Exposures Financial Product Safety
News headline image
Mirum Pharmaceuticals Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers MIRM
Exposures Financial Product Safety
News headline image
Exelixis Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers EXEL
Exposures Financial Product Safety
News headline image
GRAIL Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers GRAL SSNLF
Exposures Financial Product Safety
News headline image
Kaplan Fox Announces a Securities Class Action Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) - Lead Plaintiff Deadline is September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Akebia Therapeutics Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers AKBA
Exposures Financial Product Safety
News headline image
Bull Finder: IBRX, ANY, GTE, JLHL Plus More Surging Stocks Inside
Via AB Newswire
Topics Artificial Intelligence
Tickers ANY IBRX
Exposures Artificial Intelligence Product Safety
News headline image
Recursion Pharmaceuticals Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Artificial Intelligence Earnings
Tickers NVDA RXRX
Exposures Artificial Intelligence Financial Product Safety
News headline image
Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Geron Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers GERN
Exposures Financial Product Safety
News headline image
Compass Pathways Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Cannabis Earnings Government
Tickers CMPS
Exposures Cannabis Financial Political
News headline image
Certara (CERT) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Artificial Intelligence Earnings
Tickers CERT
Exposures Artificial Intelligence Financial Product Safety
News headline image
Precigen Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers PGEN
Exposures Financial Product Safety
News headline image
Chipotle Stops Serving Jalapenos at Certain Restaurants Due to Potential Salmonella Outbreak. Here's What Investors Need to Know. ↗
Via The Motley Fool
Topics Supply Chain
Tickers CMG
Exposures Product Safety Supply Chain
News headline image
Kaplan Fox Reminds Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Securities Class Action Deadline - Contact the Firm Before September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.